Balbontin Nathalie, Gauthier Audrey, Abalos Christine, Davis Antoinette N, Lister Meaghan
Regulatory, Operations and Emergency Management Branch, Public Health Agency of Canada, Ottawa, ON.
Can Commun Dis Rep. 2024 May 24;50(5):144-152. doi: 10.14745/ccdr.v50i05a04.
When the Public Health Agency of Canada's and came into force, the reporting of laboratory incidents to the Laboratory Incident Notification Canada (LINC) surveillance system became mandatory. This report summarizes the laboratory exposure and non-exposure data reported from 2016 to 2022, with a particular focus on factors that are not typically presented in LINC's annual report.
Reported laboratory incidents from 2016 to 2022 were analyzed. Exposures were analyzed by severity, occurrence and root cause, and affected individuals were analyzed by disease outcome, role and applied interventions. Non-exposures were analyzed by incident type. Exposure and non-exposure incident rates were calculated.
Events reported to LINC totalled 928. Of those, 355 were confirmed non-exposures, 361 were confirmed exposures, and 111 were other events. Both exposure and non-exposure incident rates per 100 active licences peaked in 2018 (9.44 and 7.11, respectively). Most exposures were rated as minor or negligible severity. The most cited exposure occurrence types were sharps-related and procedure-related (23% each), and standard operating procedure-related root causes were most cited (24%). While 781 individuals were affected in the exposure incidents, most did not develop a laboratory-acquired infection (n=753; 96%) and received at least one form of treatment post-exposure (n=717; 92%). Inadvertent possession/production cases were the most common non-exposure incidents reported.
Exposure and non-exposure incident rates have decreased since 2018. Among exposure incidents, sharps-related and procedure-related occurrences were the most common, and the root cause was usually a standard operating procedure. Non-exposure incidents were mostly inadvertent possession/production cases. Exposure and illness outcome severity was mostly minor.
当加拿大公共卫生署的[具体内容1]和[具体内容2]生效时,向加拿大实验室事件通报(LINC)监测系统报告实验室事件成为强制性要求。本报告总结了2016年至2022年报告的实验室暴露和非暴露数据,特别关注LINC年度报告中通常未呈现的因素。
对2016年至2022年报告的实验室事件进行分析。按严重程度、发生情况和根本原因对暴露事件进行分析,按疾病结果、角色和应用的干预措施对受影响个体进行分析。按事件类型对非暴露事件进行分析。计算暴露和非暴露事件发生率。
向LINC报告的事件共计928起。其中,355起为确认的非暴露事件,361起为确认的暴露事件,111起为其他事件。每100个有效许可证的暴露和非暴露事件发生率均在2018年达到峰值(分别为9.44和7.11)。大多数暴露事件被评为轻度或可忽略不计的严重程度。最常被提及的暴露发生类型是与锐器相关和与操作相关(各占23%),最常被提及的根本原因是与标准操作程序相关(24%)。虽然有781人在暴露事件中受到影响,但大多数人未发生实验室获得性感染(n = 753;96%),并且在暴露后接受了至少一种形式的治疗(n = 717;92%)。无意中持有/生产案例是报告的最常见非暴露事件。
自2018年以来,暴露和非暴露事件发生率有所下降。在暴露事件中,与锐器相关和与操作相关的发生情况最为常见,根本原因通常是标准操作程序。非暴露事件大多是无意中持有/生产案例。暴露和疾病结果严重程度大多为轻度。